SPPAM
DSCI

Summit Partners Public Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Summit Partners Public Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-46,159
Closed -$217K – 83
2015
Q3 		$217K Sell
46,159
-253,841
-85% -$1.64M 0.08% 55
2015
Q2 		$2.15M Buy
+300,000
New +$2.26M 0.75% 49

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Summit Partners Public Asset Management's DSCI Position: Q4 2015 in Review

Summit Partners Public Asset Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2015, closing a stake of 46,159 shares — an estimated $217K sold.

Summit Partners Public Asset Management first reported a position in DSCI in Q2 2015 and held it in 2 quarters. The position peaked at $2.15M in Q2 2015. 59 funds tracked by Wall St. Rank hold DSCI as of Q4 2015.

  • Summit Partners Public Asset Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2015 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 46,159 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2015, an estimated $217K.
  • Summit Partners Public Asset Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2015 and held it in 2 quarters.
  • Summit Partners Public Asset Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $2.15M in Q2 2015.
  • 59 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2015.

Based on Summit Partners Public Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.